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Pathogens and their related toxins can stimulate the produc-
tion of endogenous mediators leading to dysregulated reac-
tive oxidative stress, inﬂammatory responses, and alterations
of organ functions. Nutrition support is necessary to protect
against infectious and inﬂammatory conditions, but the
optimal nutritional formulation is still under investigation.
This special issue focuses on 5 distinct papers to deal
with the pathogens and their products (i.e., H. pylori,
LPS), speciﬁc nutrients (i.e., arginine, iron, plant extracts,
antioxidants), and intervention and mechanism of interac-
tion between various biological modiﬁers (i.e., superfamily
of cytokines, inﬂammatory markers, adhesion molecules)
involved in regulating the immune responses.
H. pylori and Iron Loss. H. pylori is an important pathogen
in the etiology of chronic gastritis and intestinal metaplasia.
Studies suggest a link between iron deﬁciency anemia and
H. pylori infection. However, the mechanism of action by
which H. pylori causes anemia is yet to be deﬁned. One
possiblemechanismisthatlactoferrincapturestheironfrom
transferrin mediated by the bacterial outer layer receptor
to initiate iron loss in the feces. In a pilot clinical trial, Y.
Do˘ gan and his collogues seek to determine the lactoferrin
l e v e l sa sam a r k e ro fa n e m i ai nH. pylori patients by means
of immunohistochemical staining.
Magnolia to Preserve Bones. Skeletal structure turnover is
organized by multifactorial regulators including cytokines
and chemokines. In this process, osteoblasts release the
osteoclastogeneticmoleculessuchasRANKLandTNF-αand
IL-6. Here, Magnolol isolated from Magnolia oﬃcinalis is
reported to signiﬁcantly block the osteoclastic diﬀerentiation
in osteoblast MC3T3-E1 cultures. Therefore, E. J. Kwak et al.
propose that Magnolol to preserve osteoblasts and possibly
to prevent bone resorption and osteoporosis.
Zerumbone and Pancreatitis. D. Wenhong et al. investigate
the eﬀects of zerumbone pretreatment on acute necrotiz-
ing pancreatitis. They suggest zerumbone to attenuate the
severityofpancreatitisaswellaspancreatitis-inducedhepatic
injurythroughNF-κBactivationinhibitionanddownregula-
tion of the ICAM-1 and IL-1β.
Arginine Deiminase and IBD. Arginine, a conditional amino
acid, is synthesized in the normal cells and tissues. Arginine
deiminase (ADI) is a key enzyme player in the cell signal-
ing pathways, apoptosis, diﬀerentiation, and transcriptional
regulation. ADI function is dysregulated in multiple human
inﬂammatory diseases and cancer. Since certain tumor
cells and pathogens require arginine for growth, selective
elimination of arginine may act as a cancer therapy and
is being investigated in human trials. While ADI is very
immunogenic with a short lifespan, when covalently mod-
iﬁed by polyethylene glycol (ADI-PEG), it becomes more
stable and less antigenic. H. S. Oz et al. challenge 2 diverse
murine models representing Crohn’s disease and ulcerative
colitis to demonstrate the protective action of this novel
microbial enzyme in attenuating inﬂammatory responses by
suppressing macrophage inﬁltration and iNOS expression.
Prediction of Survival in Sepsis. Finally, septic shock and
multiple-organ dysfunction syndrome (MODS) are associ-
ated with 40–70% mortality rate in the intensive care units.2 Mediators of Inﬂammation
T. Brenner et al. study the dysfunction of the arginine/nitric-
oxide pathway in the pathogenesis of MODS and septic
shock patients using an ELISA diagnostic technique. This
simple technique may serve as a tool to predict the survival
speciﬁcally in the severe sepsis patients with acute hepatic
failure.
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